UMBF vs ZION

UMBF presents a compelling value opportunity, characterized by a Piotroski F-Score of 4/9 (Stable) and a current price ($123.04) trading significantly below both its Graham Number ($142.0) and Intrinsic Value ($238.28). The company is demonstrating explosive top-line momentum with 67.6% YoY revenue growth and a highly consistent track record of earnings beats over the last 25 quarters. While insider selling and a bearish technical trend create short-term friction, the low Forward P/E of 9.33 and a conservative dividend payout ratio of 17.55% indicate strong fundamental health and growth potential. The valuation gap suggests the market is underpricing the company's current growth trajectory.

ZION presents a stark contrast between deep valuation discounts and deteriorating fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While the stock trades significantly below its Graham Number ($83.55) and Intrinsic Value ($189.98), the low health score and bearish insider sentiment suggest underlying operational risks. Strong year-over-year earnings growth of 38.10% provides a bullish catalyst, but this is offset by a high PEG ratio of 4.29 and a very bearish technical trend. The overall outlook is neutral as the valuation margin of safety battles fundamental fragility.